Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers

BACKGROUND: HER-2 is a key molecule serving as the therapeutic target, prognostic biomarker, and classification marker in breast cancer. Accurate microRNA profilings had not been conducted in purified tumor cells of HER-2-negative and HER-2-positive tissue specimens obtained from breast cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoqing, He, Qi, Sun, Leiqin, Zhang, Yanfei, Qin, Shengying, Fan, Junwei, Wang, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935799/
https://www.ncbi.nlm.nih.gov/pubmed/31929841
http://dx.doi.org/10.1155/2019/6057280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935799/
https://www.ncbi.nlm.nih.gov/pubmed/31929841
http://dx.doi.org/10.1155/2019/6057280

Ejemplares similares